Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus

AIMS: LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequences. This study compared the duration of action of LY IGlar and IGlar in subjects with type 1 diabetes mellitus (T1DM). MATERIALS AND METHODS: This was...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Linnebjerg, Helle, Lam, Eric Chen Quin, Zhang, Xin, Seger, Mary E., Coutant, David, Chua, Laiyi, Kapitza, Christoph, Heise, Tim
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215447/
https://ncbi.nlm.nih.gov/pubmed/27484286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12759
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky